PTC Therapeutics News

HHS Panel to Vote in Nov. on DMD Screening for Newborns

Seeking Alpha06:44

Boy Given Pfizer Experimental Duchenne Muscular Dystrophy Therapy Dies

Seeking AlphaMay 8 04:16

PTC Therapeutics to Participate at Upcoming Investor Conferences

WARREN, N.J., May 2, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the company will present a company overview at the following conferences: RBC Capital Markets 2024

PR NewswireMay 2 20:00

PTC Therapeutics, Inc. (NASDAQ:PTCT) Q1 2024 Earnings Call Transcript

Yahoo FinanceMay 1 00:25

Morgan Stanley Upgrades PTC Therapeutics to Equal-Weight, Raises Price Target to $30

Morgan Stanley analyst Jeffrey Hung upgrades PTC Therapeutics from Underweight to Equal-Weight and raises the price target from $28 to $30.

Analyst UpgradesApr 29 17:11

PTC Therapeutics Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/29/2024 4.53% Morgan Stanley $28 → $30 Upgrades Underweight → Equal-Weight 04/12/2024 56.79% Cantor Fit

BenzingaApr 29 17:09

Industry Analysts Just Made A Captivating Upgrade To Their PTC Therapeutics, Inc. (NASDAQ:PTCT) Revenue Forecasts

Yahoo FinanceApr 28 21:14

PTC Therapeutics First Quarter 2024 Earnings: Beats Expectations

Yahoo FinanceApr 27 21:12

PTC Therapeutics: A Balanced Hold Rating Amid Regulatory Challenges and Upcoming Milestones

TipRanksApr 27 07:55

Sector Update: Health Care Stocks Edge Higher Late Afternoon

Health care stocks were advancing late Friday afternoon, with the NYSE Health Care Index adding 0.2% and the Health Care Select Sector SPDR Fund (XLV) up 0.1%. The iShares Biotechnology ETF (IBB) rose

MT NewswiresApr 27 03:57

Sector Update: Health Care

Health care stocks rose late Friday afternoon with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each up 0.2%. The iShares Biotechnology ETF (IBB) added 0.9%. In corpora

MT NewswiresApr 27 03:31

Earnings Call Summary | PTC Therapeutics(PTCT.US) Q1 2024 Earnings Conference

The following is a summary of the PTC Therapeutics, Inc. (PTCT) Q1 2024 Earnings Call Transcript:Financial Performance:PTC Therapeutics reported a Q1 2024 revenue of $210 million, largely boosted by i

Futu NewsApr 27 00:47 · Conference Call

PTC Therapeutics Shares Are Trading Higher After the Company Reported Better-than-expected Q1 Financial Results and Reaffirmed Its FY24 Financial Guidance.

PTC Therapeutics Shares Are Trading Higher After the Company Reported Better-than-expected Q1 Financial Results and Reaffirmed Its FY24 Financial Guidance.

BenzingaApr 26 23:04

RBC Capital Sticks to Their Hold Rating for PTC Therapeutics (PTCT)

TipRanksApr 26 18:36

Analysts' Opinions Are Mixed on These Healthcare Stocks: Integer Holdings (ITGR), Resmed (RMD) and PTC Therapeutics (PTCT)

TipRanksApr 26 18:03

Buy Rating Affirmed for PTC Therapeutics Amidst Strong Q1 Performance and Promising Pipeline Prospects

TipRanksApr 26 17:46

Analysts Offer Insights on Healthcare Companies: BioMarin Pharmaceutical (BMRN), PTC Therapeutics (PTCT) and Teladoc (TDOC)

TipRanksApr 26 17:27

PTC Therapeutics Inc (PTCT) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth ...

Yahoo FinanceApr 26 15:35

Sell Rating on PTC Therapeutics Amid Sustainability Concerns and Market Uncertainties

TipRanksApr 26 14:36

PTC Therapeutics: A Strong Buy on Robust Financials and Favorable Regulatory Developments

TipRanksApr 26 09:25